Literature DB >> 20964335

Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation.

Lin Zhu1, Ram I Mahato.   

Abstract

Previously, we successfully conjugated galactosylated poly(ethylene glycol) (Gal-PEG) to oligonucleotides (ODNs) via an acid labile ester linker (Zhu et al., Bioconjugate Chem. 2008, 19, 290-8). In this study, sense strands of siRNA were conjugated to Gal-PEG and mannose 6-phosphate poly(ethylene glycol) (M6P-PEG) for targeted delivery of siRNAs to hepatocytes and hepatic stellate cells (HSCs), respectively. These siRNA conjugates were purified by ion exchange chromatography and verified by gel retardation assay. To evaluate their RNAi functions, the validated siRNA duplexes targeting firefly luciferase and transforming growth factor beta 1 (TGF-β1) mRNA were conjugated to Gal-PEG and M6P-PEG, and their gene silencing efficiencies were determined after transfection into HepG2 and HSC-T6 cells. The disulfide bond between PEG and siRNA was cleaved by dithiothreitol, leading to the release of intact siRNA. Both Gal-PEG-siRNA and M6P-PEG-siRNA conjugates could silence luciferase gene expression by about 40% without any transfection reagents, while the gene silencing effects reached more than 98% with the help of cationic liposomes at the same dose. Conjugation of TGF-β1 siRNA with Gal-PEG and M6P-PEG could silence endogenous TGF-β1 gene expression as well. In conclusion, these siRNA conjugates have the potential for targeted delivery of siRNAs to hepatocytes and hepatic stellate cells for efficient gene silencing in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20964335      PMCID: PMC2998752          DOI: 10.1021/bc100346n

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  40 in total

1.  Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens.

Authors:  J Hartikka; V Bozoukova; M Ferrari; L Sukhu; J Enas; M Sawdey; M K Wloch; K Tonsky; J Norman; M Manthorpe; C J Wheeler
Journal:  Vaccine       Date:  2001-02-28       Impact factor: 3.641

Review 2.  TGFbeta1 in liver fibrosis: time to change paradigms?

Authors:  M Bauer; D Schuppan
Journal:  FEBS Lett       Date:  2001-07-27       Impact factor: 4.124

Review 3.  siRNA conjugate delivery systems.

Authors:  Ji Hoon Jeong; Hyejung Mok; Yu-Kyoung Oh; Tae Gwan Park
Journal:  Bioconjug Chem       Date:  2009-01       Impact factor: 4.774

4.  Detection and relative quantification of siRNA double strands by MALDI mass spectrometry.

Authors:  Ute Bahr; Hüseyin Aygün; Michael Karas
Journal:  Anal Chem       Date:  2008-07-11       Impact factor: 6.986

5.  Targeted intracellular delivery of antisense oligonucleotides via conjugation with small-molecule ligands.

Authors:  Osamu Nakagawa; Xin Ming; Leaf Huang; Rudolph L Juliano
Journal:  J Am Chem Soc       Date:  2010-07-07       Impact factor: 15.419

6.  Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules.

Authors:  Thomas P Herringson; Joseph G Altin
Journal:  J Control Release       Date:  2009-07-10       Impact factor: 9.776

7.  TGF-beta1 gene silencing for treating liver fibrosis.

Authors:  Kun Cheng; Ningning Yang; Ram I Mahato
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

Review 8.  siRNA delivery systems for cancer treatment.

Authors:  Yu-Kyoung Oh; Tae Gwan Park
Journal:  Adv Drug Deliv Rev       Date:  2009-05-05       Impact factor: 15.470

9.  Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer.

Authors:  Sun Hwa Kim; Ji Hoon Jeong; Soo Hyeon Lee; Sung Wan Kim; Tae Gwan Park
Journal:  J Control Release       Date:  2008-03-14       Impact factor: 9.776

10.  Penetration and efficacy of VEGF siRNA using polyelectrolyte complex micelles in a human solid tumor model in-vitro.

Authors:  Ahmed M Al-Abd; Soo Hyeon Lee; Sun Hwa Kim; Jung-Ho Cha; Tae Gwan Park; Seung Jin Lee; Hyo-Jeong Kuh
Journal:  J Control Release       Date:  2009-03-21       Impact factor: 9.776

View more
  21 in total

Review 1.  Targeting collagen expression in alcoholic liver disease.

Authors:  Kyle J Thompson; Iain H McKillop; Laura W Schrum
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting.

Authors:  Lin Zhu; Pooja Kate; Vladimir P Torchilin
Journal:  ACS Nano       Date:  2012-03-14       Impact factor: 15.881

Review 3.  Subcellular fate and off-target effects of siRNA, shRNA, and miRNA.

Authors:  Saurabh Singh; Ajit S Narang; Ram I Mahato
Journal:  Pharm Res       Date:  2011-10-28       Impact factor: 4.200

4.  Multivalent cyclic RGD conjugates for targeted delivery of small interfering RNA.

Authors:  Md Rowshon Alam; Xin Ming; Michael Fisher; Jeremy G Lackey; Kallanthottathil G Rajeev; Muthiah Manoharan; Rudy L Juliano
Journal:  Bioconjug Chem       Date:  2011-07-20       Impact factor: 4.774

Review 5.  Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides.

Authors:  R L Juliano; K Carver; C Cao; X Ming
Journal:  J Drug Target       Date:  2012-11-19       Impact factor: 5.121

Review 6.  siRNA Delivery by Stimuli-Sensitive Nanocarriers.

Authors:  Giuseppina Salzano; Daniel F Costa; Vladimir P Torchilin
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

7.  Matrix Metalloproteinase-9-Responsive Nanogels for Proximal Surface Conversion and Activated Cellular Uptake.

Authors:  Mallory R Gordon; Bo Zhao; Francesca Anson; Ann Fernandez; Khushboo Singh; Celia Homyak; Mine Canakci; Richard W Vachet; S Thayumanavan
Journal:  Biomacromolecules       Date:  2018-02-08       Impact factor: 6.988

Review 8.  Delivery and targeting of miRNAs for treating liver fibrosis.

Authors:  Virender Kumar; Ram I Mahato
Journal:  Pharm Res       Date:  2014-09-04       Impact factor: 4.200

9.  Promiscuous 8-alkoxyadenosines in the guide strand of an siRNA: modulation of silencing efficacy and off-pathway protein binding.

Authors:  Uday Ghanty; Erik Fostvedt; Rachel Valenzuela; Peter A Beal; Cynthia J Burrows
Journal:  J Am Chem Soc       Date:  2012-10-11       Impact factor: 15.419

10.  Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs.

Authors:  Lin Zhu; Federico Perche; Tao Wang; Vladimir P Torchilin
Journal:  Biomaterials       Date:  2014-02-13       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.